Anti-COVID19 AKS-452 Fusion Protein Vaccine - ACT Study
NCT04681092 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 112
Last updated 2024-04-16
Summary
Combinatorial phase I/II safety, tolerability and immunogenicity single center open-label clinical study of AKS-452 COVID-19 vaccination study
Conditions
- Covid19
Interventions
- BIOLOGICAL
-
AKS-452
s.c. or i.m. vaccination
Sponsors & Collaborators
-
Akston Biosciences Corporation
collaborator UNKNOWN -
University Medical Center Groningen
lead OTHER
Principal Investigators
-
Schelto Kruijff, MD, PhD · UMCG
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- PREVENTION
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 85 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2021-04-06
- Primary Completion
- 2022-03-10
- Completion
- 2022-03-10
Countries
- Netherlands
Study Locations
More Related Trials
-
Study Assessing Safety and Immunogenicity of IC43 Vaccination Against Pseudomonas Aeruginosa in Healthy Volunteers
NCT00778388 ·Status: COMPLETED ·Phase: PHASE1
-
Effectiveness of COVID-19 Vaccines Against the SARS-COV-2 Delta (B.1.617.2)
NCT05244330 ·Status: COMPLETED
-
COVID-19 Vaccination and Breakthrough Infections Among Persons With Immunocompromising Conditions in the United States
NCT05020145 ·Status: COMPLETED
-
Evaluation of Antibody Tests for COVID-19
NCT04360954 ·Status: COMPLETED
-
The Antibiotic Guardian Study- Clinical Evaluation of a Novel, Rapid Diagnostic for Gonorrhoea and Mycoplasma Infections.
NCT05391035 ·Status: COMPLETED
-
Reducing Health Care Workers Absenteeism in Covid-19 Pandemic Through BCG Vaccine
NCT04328441 ·Status: COMPLETED ·Phase: PHASE3
-
Performance Evaluation of BCG Vaccination in Healthcare Personnel to Reduce the Severity of COVID-19 Infection.
NCT04362124 ·Status: WITHDRAWN ·Phase: PHASE3
-
Clinical Study in the Treatment of Patients With Moderate Course of COVID-19
NCT04842435 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
SARS-CoV-2 Infection in COVID-19 Vaccinated Patients
NCT05060939 ·Status: COMPLETED ·Phase: NA
-
Clinical Trial to Evaluate Mycobacterium w in Preventing COVID-19 in Subjects at Risk of Getting Infected With COVID-19
NCT04353518 ·Status: UNKNOWN ·Phase: PHASE3
-
Effects of an Antimicrobial Stewardship (AMS) Program, on the Prevalence of Multidrug-resistant Gram - Negative Pathogens, in an Area of High Consumption of Antibiotics and High Resistance Rates
NCT04261348 ·Status: UNKNOWN
-
Antimicrobial Stewardship Through MRSA Diagnosis in Emergency Department (ED) Patients With Abscesses
NCT01523899 ·Status: COMPLETED ·Phase: NA
-
LIAISON NES Influenza (FLU) A/B, Respiratory Syncytial Virus (RSV), & Coronavirus Disease 2019 (COVID-19) in Symptomatic Patients in Australia
NCT06392451 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Prevention Of Respiratory Tract Infection And Covid-19 Through BCG Vaccination In Vulnerable Older Adults
NCT04537663 ·Status: COMPLETED ·Phase: PHASE4
-
Collect Clinical Data in Chinese Patients Received CUBICIN Treatment for Actual Usage in Clinical Practice
NCT01212601 ·Status: COMPLETED
-
Atovaquone and Azithromycin Combination for Confirmed COVID-19 Infection
NCT04339426 ·Status: TERMINATED ·Phase: PHASE2
-
Clinical Trial of Mycobacterium w in COVID-19 Positive Patients, Hospitalized But Not Critically Ill
NCT04358809 ·Status: UNKNOWN ·Phase: PHASE3
-
To Evaluate SCTA01 Treatment of High-risk Outpatients With COVID-19
NCT04709328 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2/PHASE3
-
SARS-CoV-2 Infection Among Healthcare Workers
NCT05680896 ·Status: UNKNOWN
-
Study to Assess the Efficacy and Safety of STI-1558 in Adult Subjects With Mild or Moderate (COVID-19)
NCT05716425 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Evaluate a Single Dose of LTX-109 in Subjects With COVID-19 (Coronavirus Disease 2019) Infection.
NCT04854928 ·Status: UNKNOWN ·Phase: PHASE2
-
COVID-19 Vaccination AZV 2021-2023
NCT05589233 ·Status: COMPLETED
-
MRSA Decolonization in Complicated Carriage
NCT05268120 ·Status: RECRUITING ·Phase: NA
-
Feasibility and Usability of COVID-19 Antigen RDTs in Uganda
NCT05630300 ·Status: COMPLETED ·Phase: NA
-
Fast Antibiotic Susceptibility Testing for Gram Negative Bacteremia Trial
NCT06174649 ·Status: COMPLETED ·Phase: NA